Relay Therapeutics
NEWS
Relay Therapeutics was the No. 3 company in BioSpace’s NextGen Bio Class of 2018, Top 20 Life Science Startups to Watch in 2018.
Here’s a look at the top three companies from the “Top 20 Life Science Startups to Watch in 2018.”
Pharma and biotech companies from across the globe expand their leadership teams and boards.
In this week’s edition of Movers and Shakers, biopharma companies tap executives to serve in various leadership roles.
The latest financing round raises the amount of funding the company has received to more than $500 million.
As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more.
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies.
Andrew Huberman, researcher in the Stanford University Department of Neurobiology, is taking an unusual approach to investigating possible treatments for glaucoma and anxiety disorders—virtual reality.
Advances in data storage and processing, as well as biomarker identification, has led to cutting-edge breakthroughs in clinical and research imaging technology. Here’s a look at just a few of these stories.
JOBS
IN THE PRESS